APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Selected research

Market Structure

Global Sevoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025189 pages

Choose your research edition.

Industry ResearchSevoflurane Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sevoflurane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.

Read the full market overview

The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.

The report provides an overview of the global Sevoflurane market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sevoflurane and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sevoflurane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sevoflurane market size, projected growth trends, production technologies, key applications, and end-use industries.

Sevoflurane Segment by Company

Abbott

Baxter

Maruishi

Jiangsu Hengrui

Lunan

Sevoflurane Segment by Type

Generic Drug

Original Drug

Sevoflurane Segment by Application

Hospitals

Other Medical Institutions

Sevoflurane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sevoflurane market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sevoflurane industry.

Chapter 3: Detailed analysis of Sevoflurane market competition landscape. Including Sevoflurane manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Sevoflurane by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Sevoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Sevoflurane Industry Trends Table 2. Sevoflurane Industry Drivers Table 3. Sevoflurane Industry Opportunities and Challenges Table 4. Sevoflurane Industry Restraints Table 5. Global Sevoflurane Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sevoflurane Production Value Share by Manufacturers (2021-2026) Table 7. Global Sevoflurane Production by Manufacturers (K t) & (2021-2026) Table 8. Global Sevoflurane Production Market Share by Manufacturers Table 9. Global Sevoflurane Average Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Sevoflurane Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sevoflurane Manufacturers, Product Type & Application Table 13. Global Sevoflurane Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sevoflurane by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Generic Drug Table 17. Major Manufacturers of Original Drug Table 18. Global Sevoflurane Production by Type 2021 VS 2025 VS 2032 (K t) Table 19. Global Sevoflurane Production by Type (2021-2026) & (K t) Table 20. Global Sevoflurane Production by Type (2027-2032) & (K t) Table 21. Global Sevoflurane Production Market Share by Type (2021-2026) Table 22. Global Sevoflurane Production Market Share by Type (2027-2032) Table 23. Global Sevoflurane Production Value by Type 2021 VS 2025 VS 2032 (K t) Table 24. Global Sevoflurane Production Value by Type (2021-2026) & (K t) Table 25. Global Sevoflurane Production Value by Type (2027-2032) & (K t) Table 26. Global Sevoflurane Production Value Market Share by Type (2021-2026) Table 27. Global Sevoflurane Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Other Medical Institutions Table 30. Global Sevoflurane Production by Application 2021 VS 2025 VS 2032 (K t) Table 31. Global Sevoflurane Production by Application (2021-2026) & (K t) Table 32. Global Sevoflurane Production by Application (2027-2032) & (K t) Table 33. Global Sevoflurane Production Market Share by Application (2021-2026) Table 34. Global Sevoflurane Production Market Share by Application (2027-2032) Table 35. Global Sevoflurane Production Value by Application 2021 VS 2025 VS 2032 (K t) Table 36. Global Sevoflurane Production Value by Application (2021-2026) & (K t) Table 37. Global Sevoflurane Production Value by Application (2027-2032) & (K t) Table 38. Global Sevoflurane Production Value Market Share by Application (2021-2026) Table 39. Global Sevoflurane Production Value Market Share by Application (2027-2032) Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott Sevoflurane Production (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 43. Abbott Sevoflurane Product Portfolio Table 44. Abbott Recent Development Table 45. Baxter Company Information Table 46. Baxter Business Overview Table 47. Baxter Sevoflurane Production (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Baxter Sevoflurane Product Portfolio Table 49. Baxter Recent Development Table 50. Maruishi Company Information Table 51. Maruishi Business Overview Table 52. Maruishi Sevoflurane Production (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 53. Maruishi Sevoflurane Product Portfolio Table 54. Maruishi Recent Development Table 55. Jiangsu Hengrui Company Information Table 56. Jiangsu Hengrui Business Overview Table 57. Jiangsu Hengrui Sevoflurane Production (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 58. Jiangsu Hengrui Sevoflurane Product Portfolio Table 59. Jiangsu Hengrui Recent Development Table 60. Lunan Company Information Table 61. Lunan Business Overview Table 62. Lunan Sevoflurane Production (K t), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 63. Lunan Sevoflurane Product Portfolio Table 64. Lunan Recent Development Table 65. Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032 (K t) Table 66. Global Sevoflurane Production by Region (2021-2026) & (K t) Table 67. Global Sevoflurane Production Market Share by Region (2021-2026) Table 68. Global Sevoflurane Production Forecast by Region (2027-2032) & (K t) Table 69. Global Sevoflurane Production Market Share Forecast by Region (2027-2032) Table 70. Global Sevoflurane Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 71. Global Sevoflurane Production Value by Region (2021-2026) & (US$ Million) Table 72. Global Sevoflurane Production Value Share by Region (2021-2026) Table 73. Global Sevoflurane Production Value by Region (2027-2032) & (US$ Million) Table 74. Global Sevoflurane Production Value Share by Region: (2027-2032) & (US$ Million) Table 75. Global Sevoflurane Market Average Price (USD/Unit) by Region (2021-2026) Table 76. Global Sevoflurane Market Average Price (USD/Unit) by Region (2027-2032) Table 77. Global Sevoflurane Consumption by Region: 2021 VS 2025 VS 2032 (K t) Table 78. Global Sevoflurane Consumption by Region (2021-2026) & (K t) Table 79. Global Sevoflurane Consumption Market Share by Region (2021-2026) Table 80. Global Sevoflurane Consumption Forecasted by Region (2027-2032) & (K t) Table 81. Global Sevoflurane Consumption Forecasted Market Share by Region (2027-2032) Table 82. North America Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K t) Table 83. North America Sevoflurane Consumption by Country (2021-2026) & (K t) Table 84. North America Sevoflurane Consumption by Country (2027-2032) & (K t) Table 85. Europe Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K t) Table 86. Europe Sevoflurane Consumption by Country (2021-2026) & (K t) Table 87. Europe Sevoflurane Consumption by Country (2027-2032) & (K t) Table 88. Asia Pacific Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K t) Table 89. Asia Pacific Sevoflurane Consumption by Country (2021-2026) & (K t) Table 90. Asia Pacific Sevoflurane Consumption by Country (2027-2032) & (K t) Table 91. South America Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K t) Table 92. South America Sevoflurane Consumption by Country (2021-2026) & (K t) Table 93. South America Sevoflurane Consumption by Country (2027-2032) & (K t) Table 94. Middle East & Africa Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K t) Table 95. Middle East & Africa Sevoflurane Consumption by Country (2021-2026) & (K t) Table 96. Middle East & Africa Sevoflurane Consumption by Country (2027-2032) & (K t) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Sevoflurane Distributors List Table 100. Sevoflurane Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Sevoflurane Product Image Figure 2. Global Sevoflurane Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane Production Capacity (2021-2032) & (K t) Figure 5. Global Sevoflurane Production (2021-2032) & (K t) Figure 6. Global Sevoflurane Average Price (USD/Unit) & (2021-2032) Figure 7. Global Top 5 and 10 Sevoflurane Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Generic Drug Image Figure 10. Original Drug Image Figure 11. Global Sevoflurane Production by Type (2021 VS 2025 VS 2032) & (K t) Figure 12. Global Sevoflurane Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Sevoflurane Production Market Share by Type (2021-2032) Figure 14. Global Sevoflurane Production Value by Type (2021 VS 2025 VS 2032) & (K t) Figure 15. Global Sevoflurane Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sevoflurane Production Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Other Medical Institutions Image Figure 19. Global Sevoflurane Production by Application (2021 VS 2025 VS 2032) & (K t) Figure 20. Global Sevoflurane Production Market Share 2021 VS 2025 VS 2032 Figure 21. Global Sevoflurane Production Market Share by Application (2021-2032) Figure 22. Global Sevoflurane Production Value by Application (2021 VS 2025 VS 2032) & (K t) Figure 23. Global Sevoflurane Production Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sevoflurane Production Value Share by Application (2021-2032) Figure 25. Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032 (K t) Figure 26. Global Sevoflurane Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sevoflurane Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sevoflurane Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 30. Europe Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 32. South America Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Sevoflurane Production Value (2021-2032) & (US$ Million) Figure 34. North America Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 35. North America Sevoflurane Consumption Market Share by Country (2021-2032) Figure 36. U.S. Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 37. Canada Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 38. Mexico Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 39. Europe Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 40. Europe Sevoflurane Consumption Market Share by Country (2021-2032) Figure 41. Germany Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 42. France Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 43. U.K. Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 44. Italy Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 45. Netherlands Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 46. Asia Pacific Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 47. Asia Pacific Sevoflurane Consumption Market Share by Country (2021-2032) Figure 48. China Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 49. Japan Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 50. South Korea Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 51. Southeast Asia Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 52. India Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 53. Australia Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 54. South America Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 55. South America Sevoflurane Consumption Market Share by Country (2021-2032) Figure 56. Brazil Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 57. Argentina Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 58. Chile Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 59. Middle East & Africa Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 60. Middle East & Africa Sevoflurane Consumption Market Share by Country (2021-2032) Figure 61. Egypt Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 62. South Africa Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 63. Israel Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 64. Türkiye Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 65. GCC Countries Sevoflurane Consumption and Growth Rate (2021-2032) & (K t) Figure 66. Sevoflurane Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Sevoflurane Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Hospitals
  • Other Medical Institutions
Companies covered
  • Abbott
  • Baxter
  • Maruishi
  • Jiangsu Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sevoflurane Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Sevoflurane Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Sevoflurane Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Sevoflurane Market Dynamics
  1. 2.1 Sevoflurane Industry Trends
  2. 2.2 Sevoflurane Industry Drivers
  3. 2.3 Sevoflurane Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Industry Restraints
3 Sevoflurane Market by Manufacturers
  1. 3.1 Global Sevoflurane Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Sevoflurane Production by Manufacturers (2021-2026)
  3. 3.3 Global Sevoflurane Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Sevoflurane Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sevoflurane Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sevoflurane Manufacturers, Product Type & Application
  7. 3.7 Global Sevoflurane Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sevoflurane Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sevoflurane Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Sevoflurane Tier 1, Tier 2, and Tier 3
4 Sevoflurane Market by Type
  1. 4.1 Sevoflurane Type Introduction
  2. 4.1.1 Generic Drug
  3. 4.1.2 Original Drug
  4. 4.2 Global Sevoflurane Production by Type
  5. 4.2.1 Global Sevoflurane Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sevoflurane Production by Type (2021-2032)
  7. 4.2.3 Global Sevoflurane Production Market Share by Type (2021-2032)
  8. 4.3 Global Sevoflurane Production Value by Type
  9. 4.3.1 Global Sevoflurane Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sevoflurane Production Value by Type (2021-2032)
  11. 4.3.3 Global Sevoflurane Production Value Market Share by Type (2021-2032)
5 Sevoflurane Market by Application
  1. 5.1 Sevoflurane Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Other Medical Institutions
  4. 5.2 Global Sevoflurane Production by Application
  5. 5.2.1 Global Sevoflurane Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sevoflurane Production by Application (2021-2032)
  7. 5.2.3 Global Sevoflurane Production Market Share by Application (2021-2032)
  8. 5.3 Global Sevoflurane Production Value by Application
  9. 5.3.1 Global Sevoflurane Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sevoflurane Production Value by Application (2021-2032)
  11. 5.3.3 Global Sevoflurane Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Sevoflurane Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Sevoflurane Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Sevoflurane Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Sevoflurane Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Maruishi
  14. 6.3.1 Maruishi Company Information
  15. 6.3.2 Maruishi Business Overview
  16. 6.3.3 Maruishi Sevoflurane Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Maruishi Sevoflurane Product Portfolio
  18. 6.3.5 Maruishi Recent Developments
  19. 6.4 Jiangsu Hengrui
  20. 6.4.1 Jiangsu Hengrui Company Information
  21. 6.4.2 Jiangsu Hengrui Business Overview
  22. 6.4.3 Jiangsu Hengrui Sevoflurane Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Sevoflurane Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Recent Developments
  25. 6.5 Lunan
  26. 6.5.1 Lunan Company Information
  27. 6.5.2 Lunan Business Overview
  28. 6.5.3 Lunan Sevoflurane Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Lunan Sevoflurane Product Portfolio
  30. 6.5.5 Lunan Recent Developments
7 Global Sevoflurane Production by Region
  1. 7.1 Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Sevoflurane Production by Region (2021-2032)
  3. 7.2.1 Global Sevoflurane Production by Region (2021-2026)
  4. 7.2.2 Global Sevoflurane Production Forecast by Region (2027-2032)
  5. 7.3 Global Sevoflurane Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Sevoflurane Production Value by Region (2021-2032)
  7. 7.4.1 Global Sevoflurane Production Value by Region (2021-2026)
  8. 7.4.2 Global Sevoflurane Production Value by Region (2027-2032)
  9. 7.5 Global Sevoflurane Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Sevoflurane Production Value (2021-2032)
  12. 7.6.2 Europe Sevoflurane Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Sevoflurane Production Value (2021-2032)
  14. 7.6.4 South America Sevoflurane Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Sevoflurane Production Value (2021-2032)
8 Global Sevoflurane Consumption by Region
  1. 8.1 Global Sevoflurane Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Sevoflurane Consumption by Region (2021-2032)
  3. 8.2.1 Global Sevoflurane Consumption by Region (2021-2026)
  4. 8.2.2 Global Sevoflurane Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Sevoflurane Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Sevoflurane Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Sevoflurane Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Sevoflurane Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Sevoflurane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Sevoflurane Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sevoflurane Value Chain Analysis
  2. 9.1.1 Sevoflurane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sevoflurane Production Mode & Process
  6. 9.2 Sevoflurane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sevoflurane Distributors
  9. 9.2.3 Sevoflurane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst